HRP20161691T1 - Derivati ariletinila - Google Patents
Derivati ariletinila Download PDFInfo
- Publication number
- HRP20161691T1 HRP20161691T1 HRP20161691TT HRP20161691T HRP20161691T1 HR P20161691 T1 HRP20161691 T1 HR P20161691T1 HR P20161691T T HRP20161691T T HR P20161691TT HR P20161691 T HRP20161691 T HR P20161691T HR P20161691 T1 HRP20161691 T1 HR P20161691T1
- Authority
- HR
- Croatia
- Prior art keywords
- compound
- image
- following formula
- compounds
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12176662 | 2012-07-17 | ||
| PCT/EP2013/064747 WO2014012851A1 (fr) | 2012-07-17 | 2013-07-12 | Dérivés d'aryléthynyle |
| EP13735315.7A EP2875000B1 (fr) | 2012-07-17 | 2013-07-12 | Dérivés d'aryléthynyle |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20161691T1 true HRP20161691T1 (hr) | 2017-02-24 |
Family
ID=48782352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20161691TT HRP20161691T1 (hr) | 2012-07-17 | 2013-07-12 | Derivati ariletinila |
Country Status (35)
| Country | Link |
|---|---|
| US (2) | US20150133505A1 (fr) |
| EP (1) | EP2875000B1 (fr) |
| JP (1) | JP6089104B2 (fr) |
| KR (1) | KR101631041B1 (fr) |
| CN (1) | CN104364233B (fr) |
| AR (1) | AR091764A1 (fr) |
| AU (1) | AU2013292142B2 (fr) |
| BR (1) | BR112014029015A2 (fr) |
| CA (1) | CA2871389C (fr) |
| CL (1) | CL2014003160A1 (fr) |
| CO (1) | CO7111256A2 (fr) |
| CR (1) | CR20140531A (fr) |
| CY (1) | CY1118205T1 (fr) |
| DK (1) | DK2875000T3 (fr) |
| EA (1) | EA026593B1 (fr) |
| ES (1) | ES2600133T3 (fr) |
| HR (1) | HRP20161691T1 (fr) |
| HU (1) | HUE030177T2 (fr) |
| IL (1) | IL236362A (fr) |
| LT (1) | LT2875000T (fr) |
| MA (1) | MA20150280A2 (fr) |
| MX (1) | MX358998B (fr) |
| MY (1) | MY167810A (fr) |
| NZ (1) | NZ701849A (fr) |
| PE (1) | PE20150184A1 (fr) |
| PH (1) | PH12014502695A1 (fr) |
| PL (1) | PL2875000T3 (fr) |
| PT (1) | PT2875000T (fr) |
| RS (1) | RS55313B1 (fr) |
| SG (1) | SG11201407050UA (fr) |
| SI (1) | SI2875000T1 (fr) |
| TW (1) | TWI473799B (fr) |
| UA (1) | UA114911C2 (fr) |
| WO (1) | WO2014012851A1 (fr) |
| ZA (1) | ZA201408514B (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA113223C2 (xx) * | 2012-08-13 | 2016-12-26 | Арилетинілпіримідини | |
| EA026941B1 (ru) * | 2012-10-18 | 2017-06-30 | Ф. Хоффманн-Ля Рош Аг | ПРОИЗВОДНЫЕ ЭТИНИЛА В КАЧЕСТВЕ МОДУЛЯТОРОВ АКТИВНОСТИ РЕЦЕПТОРА mGluR5 |
| HRP20200638T1 (hr) | 2015-06-03 | 2020-07-10 | F. Hoffmann - La Roche Ag | Derivati etinila |
| ES2733468T3 (es) | 2015-07-15 | 2019-11-29 | Hoffmann La Roche | Derivados de etinilo como moduladores de los receptores metabotrópicos de glutamato |
| SI3484889T1 (sl) | 2016-07-18 | 2020-11-30 | F. Hoffmann-La Roche Ag | Derivati etinila |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19546462A1 (de) * | 1995-12-13 | 1997-06-19 | Bayer Ag | Diarylacetylenketone |
| PT1354875E (pt) | 2003-05-19 | 2005-03-31 | Servier Lab | Novo processo de sintese do acido (2s, 3as, 7as)-per-hidroindole-2-carboxilico e dos seus esteres e aplicacao a sintese do perindopril |
| GB0325956D0 (en) | 2003-11-06 | 2003-12-10 | Addex Pharmaceuticals Sa | Novel compounds |
| WO2006048771A1 (fr) | 2004-11-04 | 2006-05-11 | Addex Pharmaceuticals Sa | Nouveaux derives de tetrazole utilises comme modulateurs allosteriques positifs des recepteurs de glutamate metabotropiques |
| GB0510139D0 (en) | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B1 |
| NZ581817A (en) | 2007-06-03 | 2012-05-25 | Univ Vanderbilt | Benzamide mglur5 positive allosteric modulators and methods of making and using same |
| CN101544892B (zh) * | 2009-05-07 | 2012-10-03 | 石家庄诚志永华显示材料有限公司 | 一种合成二芳基乙炔类单体液晶的方法 |
| US8420661B2 (en) * | 2010-04-13 | 2013-04-16 | Hoffmann-La Roche Inc. | Arylethynyl derivatives |
| KR101554803B1 (ko) * | 2011-04-26 | 2015-09-21 | 에프. 호프만-라 로슈 아게 | Mglur5의 양성 알로스테릭 조절체로서 에틴일 유도체 |
-
2013
- 2013-07-12 WO PCT/EP2013/064747 patent/WO2014012851A1/fr not_active Ceased
- 2013-07-12 NZ NZ701849A patent/NZ701849A/en not_active IP Right Cessation
- 2013-07-12 DK DK13735315.7T patent/DK2875000T3/en active
- 2013-07-12 HU HUE13735315A patent/HUE030177T2/en unknown
- 2013-07-12 MY MYPI2014003059A patent/MY167810A/en unknown
- 2013-07-12 SI SI201330415A patent/SI2875000T1/sl unknown
- 2013-07-12 PT PT137353157T patent/PT2875000T/pt unknown
- 2013-07-12 PL PL13735315T patent/PL2875000T3/pl unknown
- 2013-07-12 JP JP2015521004A patent/JP6089104B2/ja not_active Expired - Fee Related
- 2013-07-12 SG SG11201407050UA patent/SG11201407050UA/en unknown
- 2013-07-12 MA MA37795A patent/MA20150280A2/fr unknown
- 2013-07-12 LT LTEP13735315.7T patent/LT2875000T/lt unknown
- 2013-07-12 EA EA201492274A patent/EA026593B1/ru not_active IP Right Cessation
- 2013-07-12 AU AU2013292142A patent/AU2013292142B2/en not_active Ceased
- 2013-07-12 CA CA2871389A patent/CA2871389C/fr not_active Expired - Fee Related
- 2013-07-12 PE PE2014002231A patent/PE20150184A1/es active IP Right Grant
- 2013-07-12 CN CN201380031736.9A patent/CN104364233B/zh active Active
- 2013-07-12 KR KR1020157001019A patent/KR101631041B1/ko not_active Expired - Fee Related
- 2013-07-12 EP EP13735315.7A patent/EP2875000B1/fr active Active
- 2013-07-12 BR BR112014029015A patent/BR112014029015A2/pt not_active Application Discontinuation
- 2013-07-12 UA UAA201500231A patent/UA114911C2/uk unknown
- 2013-07-12 ES ES13735315.7T patent/ES2600133T3/es active Active
- 2013-07-12 HR HRP20161691TT patent/HRP20161691T1/hr unknown
- 2013-07-12 RS RS20160979A patent/RS55313B1/sr unknown
- 2013-07-12 MX MX2014014950A patent/MX358998B/es active IP Right Grant
- 2013-07-15 AR ARP130102507 patent/AR091764A1/es not_active Application Discontinuation
- 2013-07-16 TW TW102125419A patent/TWI473799B/zh not_active IP Right Cessation
-
2014
- 2014-10-23 CO CO14235289A patent/CO7111256A2/es unknown
- 2014-11-19 ZA ZA2014/08514A patent/ZA201408514B/en unknown
- 2014-11-20 CR CR20140531A patent/CR20140531A/es unknown
- 2014-11-21 CL CL2014003160A patent/CL2014003160A1/es unknown
- 2014-12-03 PH PH12014502695A patent/PH12014502695A1/en unknown
- 2014-12-18 IL IL236362A patent/IL236362A/en active IP Right Grant
-
2015
- 2015-01-15 US US14/597,375 patent/US20150133505A1/en not_active Abandoned
- 2015-10-26 US US14/923,308 patent/US9328090B2/en active Active
-
2016
- 2016-11-04 CY CY20161101133T patent/CY1118205T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ME02892B (fr) | Composés chimiques | |
| CA2826751C (fr) | Procedes de synthese de quinoleines et compositions pharmaceutiques les incluant | |
| PH12017501061B1 (en) | 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection | |
| MD4490B1 (ro) | Noi compuşi de indolizină, procedeu de obţinere a lor şi compoziţii farmaceutice care îi conţin | |
| EA201001683A1 (ru) | Производные фенил- или пиридинилзамещенных индазолов | |
| JP2015500843A5 (fr) | ||
| PH12014502524A1 (en) | Carboxylic acid compounds | |
| MX392440B (es) | Inhibidores de tirosina quinasa de bazo (syk). | |
| EA201200471A1 (ru) | Простые эфирные производные бициклических гетероарилов | |
| MD20140073A2 (en) | New phosphate compounds, a process for their preparation and pharmaceutical compositions containing them | |
| EA201592255A1 (ru) | Производные пиразолопирролидин-4-она в качестве ингибиторов вет и их применение при лечении заболевания | |
| EA201591804A1 (ru) | Производные 2-((4-амино-3-(3-фтор-5-гидроксифенил)-1h-пиразоло[3,4-d]пиримидин-1-ил)метил)-3-(2-(трифторметил)бензил)хиназолин-4(3h)-она и их применение в качестве ингибиторов фосфоинозитид-3-киназы | |
| AR086100A1 (es) | Compuestos de cromenona y composiciones farmaceuticas que los contienen | |
| EA201690072A1 (ru) | Состав, содержащий гиполипидемическое средство | |
| CA2920410C (fr) | Derive thienopiperidine et son utilisation | |
| NZ603108A (en) | 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators | |
| MX2016009581A (es) | Derivados de 6-fenil- o 6-(piridin-3-il) indazol y metodos de uso. | |
| MX2016009621A (es) | Derivados de fur0-3-carboxamida y metodos de uso. | |
| ME02351B (fr) | Dérivés de 2-oxo-1-imidazolidinyl imidazothiadiazole | |
| WO2014014794A3 (fr) | Antagonistes des récepteurs aux minéralocorticoïdes | |
| PH12015502717B1 (en) | Anti-fibrogenic compounds, methods and uses thereof | |
| WO2014160143A3 (fr) | Composés d'isatine, compositions et procédés pour le traitement de maladies et de troubles dégénératifs | |
| NZ701849A (en) | Arylethynyl derivatives | |
| UA117780C2 (uk) | Похідні азаіндолоцтової кислоти та їх застосування як модуляторів рецепторів простагландину d2 | |
| JP2014508170A5 (fr) |